Skip to main content

International Journal of Clinical Oncology

Ausgabe 3/2023

Including Invited Reviews on Association of microbiome with cancer treatment

Inhalt (18 Artikel)

Invited Review Article

Association of microbiota with cancer treatment

Kiyoshi Yoshimura

Review Article

Insight into autophagy in platinum resistance of cancer

Fang Yang, Ke Xu, Yan-Gang Zhou, Tao Ren

Open Access Original Article

Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies

Teresita Caruso, Francesca Salani, Silvia Catanese, Federico Pratesi, Chiara Mercinelli, Giuseppe Motta, Virginia Genovesi, Adele Bonato, Galimberti Sara, Gianluca Masi, Paola Migliorini

Open Access Correction

Correction to: Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies

Teresita Caruso, Francesca Salani, Silvia Catanese, Federico Pratesi, Chiara Mercinelli, Giuseppe Motta, Virginia Genovesi, Adele Bonato, Galimberti Sara, Gianluca Masi, Paola Migliorini

Original Article

Association of chemotherapy and comorbidities with overall survival in elderly patients with early breast cancer: a French population-based propensity score-matched analysis

Pauline Corbaux, Catherine Terret, Claire Cropet, Sylvie Chabaud, Chiara Russo, Christelle Faure, Olivier Tredan, Thomas Bachelot, Pierre-Etienne Heudel

Original Article

Long-term results of chemoradiotherapy with elective nodal irradiation for resectable locally advanced esophageal cancer in three-dimensional planning system

Shota Miyoshi, Ikuno Nishibuchi, Yuji Murakami, Tsuyoshi Katsuta, Nobuki Imano, Junichi Hirokawa, Yoichi Hamai, Manabu Emi, Morihito Okada, Yasushi Nagata

Original Article

Long-term results of a phase 2 study of neoadjuvant chemotherapy with molecularly targeted agents for locally advanced rectal cancer

Ryuhei Aoyama, Koya Hida, Suguru Hasegawa, Takashi Yamaguchi, Dai Manaka, Shigeru Kato, Masahiro Yamada, Satoshi Yamanokuchi, Takahisa Kyogoku, Akiyoshi Kanazawa, Kenji Kawada, Takashi Sakamoto, Saori Goto, Yoshiharu Sakai, Kazutaka Obama

Original Article

The impact of the advanced lung cancer inflammation index on the outcomes of patients with metastatic colorectal cancer who receive chemotherapy

Taichi Horino, Ryuma Tokunaga, Yuji Miyamoto, Yukiharu Hiyoshi, Takahiko Akiyama, Nobuya Daitoku, Yuki Sakamoto, Naoya Yoshida, Hideo Baba

Original Article

Efficacy and safety of nivolumab with ipilimumab for recurrent malignant pleural mesothelioma after primary surgical intervention

Akifumi Nakamura, Masaki Hashimoto, Nobuyuki Kondo, Seiji Matsumoto, Ayumi Kuroda, Toshiyuki Minami, Kazuhiro Kitajima, Kozo Kuribayashi, Takashi Kijima, Seiki Hasegawa

Open Access Original Article

Final efficacy and safety results and biomarker analysis of a phase 2 study of cabozantinib in Japanese patients with advanced renal cell carcinoma

Noboru Nakaigawa, Yoshihiko Tomita, Satoshi Tamada, Katsunori Tatsugami, Takahiro Osawa, Mototsugu Oya, Hiroomi Kanayama, Yuji Miura, Naoto Sassa, Kazuo Nishimura, Masahiro Nozawa, Naoya Masumori, Yasuhide Miyoshi, Shingo Kuroda, Akiko Kimura

Original Article

The presence of lymph node metastases and time to castration resistance predict the therapeutic effect of enzalutamide for castration-resistant prostate cancer

Toshiki Oka, Koji Hatano, Yohei Okuda, Akinaru Yamamoto, Toshihiro Uemura, Gaku Yamamichi, Eisuke Tomiyama, Yu Ishizuya, Yoshiyuki Yamamoto, Taigo Kato, Atsunari Kawashima, Kazutoshi Fujita, Norio Nonomura

Original Article

JGOG2046: a feasibility study of neoadjuvant chemotherapy followed by debulking surgery for clinically diagnosed FIGO stage IVb endometrial cancer

Toru Nakanishi, Toshiaki Saito, Daisuke Aoki, Yo Watanabe, Kimio Ushijima, Masashi Takano, Toru Sugiyama, Nobuo Yaegashi, Kazuhiro Takehara

Original Article

Real-world practice of estrogen therapy after surgery for endometrial cancer: a descriptive study using a Japanese claims database

Yoshihide Inayama, Kayoko Mizuno, Ken Yamaguchi, Junzo Hamanishi, Masato Takeuchi, Miho Egawa, Masaki Mandai, Koji Kawakami

Original Article

Association between financial toxicity and health-related quality of life of patients with gynecologic cancer

Yusuke Kajimoto, Kazunori Honda, Shiro Suzuki, Masahiko Mori, Hirofumi Tsubouchi, Kohshiro Nakao, Anri Azuma, Takashi Shibutani, Shoji Nagao, Takahiro Koyanagi, Izumi Kohara, Shuko Tamaki, Midori Yabuki, Lida Teng, Keiichi Fujiwara, Ataru Igarashi

Original Article

Reciprocal expression of the immune response genes CXCR3 and IFI44L as module hubs are associated with patient survivals in primary central nervous system lymphoma

Yasuo Takashima, Momoko Hamano, Kengo Yoshii, Azusa Hayano, Junya Fukai, Yasuo Iwadate, Koji Kajiwara, Hiroaki Hondoh, Ryuya Yamanaka

Original Article

Which modality is better to diagnose high-grade transformation in retroperitoneal liposarcoma? Comparison of computed tomography, positron emission tomography, and magnetic resonance imaging

Yu Nakashima, Yukihiro Yokoyama, Hiroshi Ogawa, Ayako Sakakibara, Masaki Sunagawa, Yoshihiro Nishida, Takashi Mizuno, Junpei Yamaguchi, Shunsuke Onoe, Nobuyuki Watanabe, Shoji Kawakatsu, Tsuyoshi Igami, Tomoki Ebata

Open Access Correction

Correction to: Definitive radiotherapy consisting of whole pelvic radiotherapy with no central shielding and CT-based intracavitary brachytherapy for cervical cancer: feasibility, toxicity, and oncologic outcomes in Japanese patients

Takeaki Kusada, Takafumi Toita, Takuro Ariga, Wataru Kudaka, Hitoshi Maemoto, Wataru Makino, Kazuki Ishikawa, Joichi Heianna, Yutaka Nagai, Yoichi Aoki, Sadayuki Murayama

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.